0
Article |

Hyperactivity and Medication-Reply FREE

JAMES R. VARGA, MD
Am J Dis Child. 1979;133(12):1288. doi:10.1001/archpedi.1979.02130120079020.
Text Size: A A A
Published online

In Reply.—I share many of Dr Smith's concerns regarding the use of stimulant medication in children with attentional difficulties. I do believe that he overstates the potential for harm with regard to the long-term cardiovascular effects. The overwhelming majority of follow-up studies do not indicate that this is a major problem area. The work by Sprague and Slater1 suggests that our end points for titrating medication effect may need to differentiate between learning and behavioral phenomena. This is a development that I strongly encourage and have emphasized in the article.

It is not my intention or desire to suggest that medication should be the mainstay of therapy. It is helpful for carefully selected children as part of a more comprehensive program that uses educational and behavioral intervention strategies. Rather than reserving its use for situations where "all else fails" as recommended by Dr Smith, I would suggest a

REFERENCES

Sprague R, Slater E:  Methylphenidate in hyperkinetic children: Differences in dose effects on learning and social behavior . Science 198:1274, 1977;.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Sprague R, Slater E:  Methylphenidate in hyperkinetic children: Differences in dose effects on learning and social behavior . Science 198:1274, 1977;.

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.